QNZ46

SKU: orb1305595

Description

QNZ46 is a selective non-competitive antagonist targeting NMDA receptors containing the NR2C or NR2D subunits. It is a valuable research tool for studying synaptic plasticity, neuropathic pain mechanisms, and the role of specific NMDA receptor subtypes in both in vitro and in vivo neurological models.

Research Area

Neuroscience, Pharmacology & Drug Discovery

Key Properties

• CAS Number: 1237744-13-6
• MW: 443.41
• Purity: 99.65% (May vary between batches)
• Formula: C₂₄H₁₇N₃O₆
• SMILES: COc1ccc2nc(\C=C\c3cccc(c3)[N+]([O-])=O)n(-c3ccc(cc3)C(O)=O)c(=O)c2c1
• Target: NMDAR,iGluR
• Solubility: DMSO:4.44 mg/mL (10.01 mM)

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

iGluR, Inhibitor, NR2C, NR2D, NR2A, inhibit, Ionotropic glutamate receptors, QNZ 46, QNZ46, QNZ-46

Compound Identifiers

PubChem CID

46861929